National Biotech Week to Launch in VancouverNational Biotech Week (NBW) will be held across Canada from September 23rd to 30th. This week is a celebration of the imagination and innovation of Canadian scientists from Vancouver to St. John's. Every region of the country will be participating in this national program designed to inform Canadians and showcase Canadian excellence. With over 30 partners to the program, National Biotechnology Week is a proven success.BC Biotech is pleased to announce that this year, the National Biotech Week Launch Event will be held in Vancouver, BC on September 21st. Stay tuned for further details.
Mark your calendars for the following events during NBW in September:
September 21, 2006 NBW Launch Event September 27, 2006 Crimes, Passion and Biotechnology Seminar (for high school students) September 28, 2006 BC Biotech AGM
On June 5-6, 2006, top health care professionals, senior policy makers, technology officials and academics met in Kelowna BC to examine key technologies such as biotechnology, medical devices, pharmaceuticals, genomics, nanotechnology, facility design, information, communication, research and development to support the achievement of the vision for health care. This two-day symposium consisted of presentations, panels, sessions and public debates in all technology areas and brought together leaders in every sector.
The Canadian Consulate in Raleigh, NC, and the Canadian Consulate General in Atlanta, GA, recently organized a Mission from the southeastern USA focused on ‘omics’ technologies, nanotechnology and their convergence. This Omics-Nano Mission also visited British Columbia and Alberta from June 4th to 9th. The primary purpose of the Mission was to foster Canadian-US business alliances as well as collaborative research and development in both nanotechnology and the “omics” area (including genomics, proteomics, metabolomics, and bioinformatics) as well as in the convergence of nanotechnology and biotechnology. This was an Enhanced Representative Initiative (ERI) and the ERI Partners for this Mission were the National Research Council Canada and Western Economic Diversification Canada. The Vancouver portion of the Mission was organized by a BC Host Committee comprised of representatives from BC Biotech, Genome BC, BCCA, Nano BC, International Trade Canada, NRC-IRAP, and Western Economic Diversification. The Mission took place at Genome BC and BC Cancer Agency. Some of the session topics focused on Drug Development and Medical Devices; Nano, Omics and Drug Delivery; Bio Business and Cancer Genomics. In particular, Gowlings gave an insightful presentation on the "Current Issues in IP Protection of Genomics, Proteomics & Nanotechnology".
Dr. John Hepburn, Vice President of Research from UBC hosted the event along with co-host Dr. Robert Dynes, President of the University of California. Dr. Arthur Carty, National Science Advisor of the Privy Council Office of Canada was the keynote speaker. Taiwanese Delegation of MBA Executive Students Visit British ColumbiaBC Biotech was pleased to present to a group of Executive MBA Students visiting British Columbia on June 16th . The group was coordinated by UVIC, and represented different industries holding various job titles in many sectors but were particularly interested in biotechnology. Karimah Es Sabar, Executive Director of BC Biotech gave a presentation on BC's biotechnology sector outlining the opportunities and successes we have achieved as a cluster to date.
Eleven delegates from BC met with senior business leaders from San Diego to discuss the issues listed above. The delegates were hosted by Steve Morley, VP of Technology of QUALCOMM which is one of the world's leading wireless technology firm. The delegation also visited the Salk Institute which conducts world-class biological research under the guidance of 59 faculty investigators. It employs a scientific staff of more than 850, including visiting scientists, postdoctoral fellows, and graduate students. The major areas of study are: Molecular Biology and Genetics; Neurosciences; and Plant Biology.
BC Biotech is pleased to announce that we are now authorized to extend access to the Canada Export Centre for qualified members. The Canada Export Centre acts like a permanent export trade-show that exhibits and promotes Canadian companies’ products and services to foreign trade missions and other qualified international buyers, investors, distributors, agents, government representatives and joint venture partners from around the world - 12 months of the year. They also provide market intelligence and international market development services to Canadian companies. BC Biotech is one of only 64 associations nationwide to qualify for the federal government’s PEMD Program to promote exports. The PEMD Program has just announced that it will financially support a finite number of BC Biotech member companies to participate in the Canada Export Centre by covering 50% of the fees and associated costs for up to three years. There are other eligible associations and only a small number of spaces available, so we strongly encourage you take the time to analyze this opportunity before it disappears. Expect a call from the Canada Export Centre to determine if their services and your organization are well matched. At BC Biotech, we are always working to maximize the value of your member-ship. Only through this partnership with PEMD and the Canada Export Centre are we able to bring you this extraordinary government funding opportunity. For more information please contact Mark Mensing at the Canada Export Centre at 604-685-7823 ext.# 116 mark@canadaexportcentre.com
Join luminaries from the spheres of science, finance, business, law and government policy as a speaker at the next Bio International Convention, May 6-9, 2007 in Boston, MA USA. Apply to Present at BioPartnering North America 2007Now in it’s 5th year, BioPartnering North America (BPN) www.techvision.com/bpn is supported by leading pharmaceutical, biotechnology, financial, and service companies from around the world. This key partnering meeting, held in Vancouver, offer companies a focused business development experience that is consistently excellent, efficient, and cost-effective. To register online, visit www.techvision.com/bpn/registration . A hallmark of BPN is the Open House Presentations that features 56 biopharmaceutical and diagnostics companies that give interactive presentations in specially constructed booths. Presenting companies are available during a 2-hour period for informal discussions with business development executives. Presenting companies devise unique ways to showcase aspects of their businesses including: science and technology; partnering strategies; developmental programs; commercialization plans; product opportunities; and manufacturing capabilities. To apply for an Open House Company Presentation go to www.techvision.com/bpn/registration/presenter/ohapply . BPN showcases a number of young companies from various parts of the world in the Emerging Company presentations. Twenty companies founded in or after 2003 will offer 14-minute podium presentations in the main plenary hall. Each company will then be available for private discussions directly afterwards. To apply for and Emerging Company presentation go to www.techvision.com/bpn/registration/presenter/ecapply . If you have any questions about registering for BPN, please contact Saskia Baur at +1.831.464.4230 or by email at sbaur@techvision.com . For questions regarding company presentations, please contact Lila Taylor at +1.831.464.4230 or by e-mail at ltaylor@techvision.com |
 Suite 900 - 1188 West Georgia St.
Vancouver, BC V6E 4A2 |